Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 7.36
+0.01 (0.14%)
Aug 19, 2026, 9:54 AM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 353.26 million as of August 18, 2026. Its market cap has decreased by -39.13% in one year.
Market Cap
353.26M
Enterprise Value
897.12M
Revenue
187.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.36
ChartMarket Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 353.26M, a decrease of -67.36%. That is a compound annual growth rate of -17.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 370.92M | -25.76% |
| Dec 31, 2025 | 499.60M | -30.53% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.00B |
| DIVA Laboratories | 1.94B |
| Puriblood Medical | 1.11B |
| Genetics Generation Advancement | 1.07B |
| Kim Forest Enterprise | 775.93M |
| Sofiva Genomics | 726.62M |
| TFBS Bioscience | 719.75M |
| Welgene Biotech | 391.51M |